Molecular approximations between residues 21 and 23 of secretin and its receptor: Development of a model for peptide docking with the amino terminus of the secretin receptor

Molecular Pharmacology

Volumn 72, Issue 2, 2007, Pages 280-290

  Dong, Maoqing ^a   Lam, Polo C H ^b   Gao, Fan ^a   Hosohata, Keiko ^a   Pinon, Delia I ^a   Sexton, Patrick M ^c   Abagyan, Ruben ^b   Miller, Laurence J ^a,d  

^a MAYO GRADUATE SCHOOL   (United States)

^b MOLSOFT LLC   (United States)

^c MONASH UNIVERSITY   (Australia)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; SECRETIN; SECRETIN RECEPTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; COVALENT BOND; LIGAND BINDING; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION; SEQUENCE ANALYSIS;

AFFINITY LABELS; AMINO ACID SEQUENCE; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GASTROINTESTINAL HORMONE; SECRETIN;

EID: 34547190765     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.035402     Document Type: Article

References (40)

1. Abagyan R and Totrov M (1994) Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. J Mol Biol 235:983-1002.
2. Abagyan R, Totrov M, and Kuznetsov D (1994) ICM- a new method for protein modeling and design: applications to docking and structure prediction from the distorted native confirmation. J Comput Chem 15:488-506.
3. Abagyan RA and Totrov M (1999) Ab initio folding of peptides by the optimal-bias Monte Carlo minimization procedure. J Comput Phys 151:402-421.
4. Bisello A, Adams AE, Mierke DF, Pellegrini M, Rosenblatt M, Suva LJ, and Chorev M (1998) Parathyroid hormone-receptor interactions identified directly by photocross-linking and molecular modeling studies. J Biol Chem 273:22498-22505.
5. Boeckmann B, Bairoch A, Apweiler R, Blatter MC, Estreicher A, Gasteiger E, Martin MJ, Michoud K, O'Donovan C, Phan I, et al. (2003) The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res 31:365-370.
6. Bordner AJ and Abagyan R (2006) Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes. Proteins 63:512-526.
7. Cao YJ, Gimpl G, and Fahrenholz F (1995) The amino-terminal fragment of the adenylate cyclase activating polypeptide (PACAP) receptor functions as a high affinity PACAP binding domain. Biochem Biophys Res Commun 212:673-680.
8. Cardozo T, Totrov M, and Abagyan R (1995) Homology Modeling by the Icm Method. Proteins 23:403-414.
9. Clore GM, Nilges M, Brunger A, and Gronenborn AM (1988) Determination of the backbone conformation of secretin by restrained molecular dynamics on the basis of interproton distance data. Eur J Biochem 171:479-484.
10. Dong M, Asmann YW, Zang M, Pinon DI, and Miller LJ (2000) Identification of two pairs of spatially approximated residues within the carboxyl terminus of secretin and its receptor. J Biol Chem 275:26032-26039.
11. Dong M, Li Z, Pinon DI, Lybrand TP, and Miller LJ (2004) Spatial approximation between the amino terminus of a peptide agonist and the top of the sixth transmembrane segment of the secretin receptor. J Biol Chem 279:2894-2903.
12. Dong M, Li Z, Zang M, Pinon DI, Lybrand TP, and Miller LJ (2003) Spatial approximation between two residues in the mid-region of secretin and the amino terminus of its receptor. Incorporation of seven sets of such constraints into a three-dimensional model of the agonist-bound secretin receptor. J Biol Chem 278:48300-48312.
13. Dong M, Pinon DI, Asmann YW, and Miller LJ (2006) Possible endogenous agonist mechanism for the activation of secretin family G protein-coupled receptors. Mol Pharmacol 70:206-213.
14. Dong M, Wang Y, Hadac EM, Pinon DI, Holicky E, and Miller LJ (1999a) Identification of an interaction between residue 6 of the natural peptide ligand and a distinct residue within the amino-terminal tail of the secretin receptor. J Biol Chem 274:19161-19167.
15. Dong M, Wang Y, Pinon DI, Hadac EM, and Miller LJ (1999b) Demonstration of a direct interaction between residue 22 in the carboxyl-terminal half of secretin and the amino-terminal tail of the secretin receptor using photoaffinity labeling. J Biol Chem 274:903-909.
16. Dong M, Zang M, Pinon DI, Li Z, Lybrand TP, and Miller LJ (2002) Interaction among four residues distributed through the secretin pharmacophore and a focused region of the secretin receptor amino terminus. Mol Endocrinol 16:2490-2501.
17. Fernández-Recio J, Totrov M, and Abagyan R (2003) ICM-DISCO docking by global energy optimization with fully flexible side-chains. Proteins 52:113-117.
18. Frimurer TM and Bywater RP (1999) Structure of the integral membrane domain of the GLP1 receptor. Proteins 35:375-386.
19. Ganguli SC, Park CG, Holtmann MH, Hadac EM, Kenakin TP, and Miller LJ (1998) Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis. J Pharmacol Exp Ther 286:593-598.
20. Gourlet P, Vilardaga JP, De Neef P, Waelbroeck M, Vandermeers A, and Robberecht P (1996) The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors. Peptides 17:825-829.
21. Grace CR, Perrin MH, DiGruccio MR, Miller CL, Rivier JE, Vale WW, and Riek R (2004) NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor. Proc Natl Acad Sci U S A 101:12836-12841.
22. Grauschopf U, Lilie H, Honold K, Wozny M, Reusch D, Esswein A, Schafer W, Rucknagel KP, and Rudolph R (2000) The N-terminal fragment of human parathyroid hormone receptor 1 constitutes a hormone binding domain and reveals a distinct disulfide pattern. Biochemistry 39:8878-8887.
23. Hadac EM, Ghanekar DV, Holicky EL, Pinon DI, Dougherty RW, and Miller LJ (1996) Relationship between native and recombinant cholecystokinin receptors: role of differential glycosylation. Pancreas 13:130-139.
24. Hooft RWW, Vriend G, Sander C, and Abola EE (1996) Errors in protein structures. Nature 381:272.
25. Juppner H, Schipani E, Bringhurst FR, McClure I, Keutmann HT, Potts JT Jr, Kronenberg HM, Abou-Samra AB, Segre GV, and Gardella TJ (1994) The extra-cellular amino-terminal region of the parathyroid hormone (PTH)/PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-(1-34). Endocrinology 134:879-884.
26. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
27. Laskowski RA, Macarthur MW, Moss DS, and Thornton JM (1993) Procheck - a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283-291.
28. Lisenbee CS, Dong M, and Miller LJ (2005) Paired cysteine mutagenesis to establish the pattern of disulfide bonds in the functional intact secretin receptor. J Biol Chem 280:12330-12338.
29. Metropolis N, Rosenbluth AW, Rosenbluth MN, Teller AH, and Teller E (1953) Equation of state calculations by fast computing machines. J Chem Phys 21:1087-1092.
30. Munson PJ and Rodbard D (1980) Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
31. Nederveen AJ, Doreleijers JF, Vranken W, Miller Z, Spronk C, Nabuurs SB, Guntert P, Livny M, Markley JL, Nilges M, et al. (2005) RECOORD: A recalculated coordinate database of 500+ proteins from the PDB using restraints from the BioMagResBank. Proteins 59:662-672.
32. Nemethy G, Gibson KD, Palmer KA, Yoon CN, Paterlini G, Zagari A, Rumsey S, and Scheraga HA (1992) Energy parameters in polypeptides. 10. Improved geometrical parameters and nonbonded interactions for use in the ECEPP/3 algorithm, with application to proline-containing peptides. J Phys Chem 96:6472-6484.
33. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, et al. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289:739-745.
34. Pearson RK, Miller LJ, Hadac EM, and Powers SP (1987) Analysis of the carbohydrate composition of the pancreatic plasmalemmal glycoprotein affinity labeled by short probes for the cholecystokinin receptor. J Biol Chem 262:13850-13856.
35. Pham V, Wade JD, Purdue BW, and Sexton PM (2004) Spatial proximity between a photolabile residue in position 19 of salmon calcitonin and the amino terminus of the human calcitonin receptor. J Biol Chem 279:6720-6729.
36. Powers SP, Pinon DI, and Miller LJ (1988) Use of N,O-bis-Fmoc- D-Tyr-ONSu for introduction of an oxidative iodination site into cholecystokinin family peptides. Int J Pept Protein Res 31:429-434.
37. Tan YV, Couvineau A, Murail S, Ceraudo E, Neumann JM, Lacapere JJ, and Laburthe M (2006) Peptide agonist docking in the N-terminal ectodomain of a class II G protein-coupled receptor, the VPAC1 receptor. Photoaffinity, NMR, and molecular modeling. J Biol Chem 281:12792-12798.
38. Ulrich CD 2nd, Holtmann M, and Miller LJ (1998) Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors. Gastroenterology 114:382-397.
39. Ulrich CD 2nd, Pinon DI, Hadac EM, Holicky EL, Chang-Miller A, Gates LK, and Miller LJ (1993) Intrinsic photoaffinity labeling of native and recombinant rat pancreatic secretin receptors. Gastroenterology 105:1534-1543.
40. Zang M, Dong M, Pinon DI, Ding XQ, Hadac EM, Li Z, Lybrand TP, and Miller LJ (2003) Spatial approximation between a photolabile residue in position 13 of secretin and the amino terminus of the secretin receptor. Mol Pharmacol 63:993-1001.